Compounds > feracryl
Page last updated: 2024-11-08

feracryl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Feracryl: according to Unlisted Drugs, feracryl is an acrylic acid polymer containing 0.5-2.5% iron [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID171450
MeSH IDM0141780

Synonyms (15)

Synonym
feracryl
iron acrylate
iron triacrylate
2-propenoic acid, iron(3+) salt
55488-18-1
2-propenoic acid, iron(3+) salt (3:1)
einecs 259-667-3
iron(3+) acrylate
einecs 239-865-6
15773-23-6
iron(iii) acrylate
AKOS025295463
WNWBIDPJHFYYLM-UHFFFAOYSA-K
iron(3+);prop-2-enoate
DTXSID00890887

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The plaster exerts no local irritative, resorptive toxic effect on tissues and possesses no allergenic properties."( [Specific activity and toxicity of hemostatic feracryl-based plaster].
Ekimov, VV; Kitaeva, RI; Leonov, VI; Reznikov, KM; Zaporozhko, LV, )		0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (8.33%)4.05%
Observational0 (0.00%)0.25%
Other9 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
aminocaproic acid
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.. 6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.		3.7621amino acid zwitterion;
epsilon-amino acid;
omega-amino fatty acid		antifibrinolytic drug;
hematologic agent;
metabolite
adenosine
quinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlit		2.0810adenosines;
purines D-ribonucleoside		analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
povidone-iodine
Povidone-Iodine: An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes.		710
ConditionIndicatedRelationship StrengthStudiesTrials
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.		02.0810
Absence Seizure
[description not available]		02.0810
Seizures
Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.		02.0810
Dentin, Secondary
Dentin formed by normal pulp after completion of root end formation.		01.9910
Pulmonary Consumption
[description not available]		03.7621
Hemoptysis
Expectoration or spitting of blood originating from any part of the RESPIRATORY TRACT, usually from hemorrhage in the lung parenchyma (PULMONARY ALVEOLI) and the BRONCHIAL ARTERIES.		03.7621
Tuberculosis, Pulmonary
MYCOBACTERIUM infections of the lung.		03.7621
Gastroesophageal Laceration-Hemorrhage
[description not available]		01.9610